Should I buy or sell Neovasc stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NVC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVC, but not buy additional shares or sell existing shares. View NVC analyst ratings or view top-rated stocks .

What other stocks do shareholders of Neovasc own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Neovasc (NVCN) , PPL (PPL) , Ballard Power Systems (BLDP) , (CPXX) (CPXX) , 155675 (BLD.TO) (BLD) , Dundee Precious Metals (DPM) , Fc Global Realty (FCRE) , Top Ships (TOPS) and Birchcliff Energy (BIR) .

How do I buy shares of Neovasc?

Shares of NVC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

Neovasc Stock Price, News & Analysis (TSE:NVC)

Today's Range: N/A
50-Day Range: C$1.78
▼
C$1.78
52-Week Range: N/A

Volume: 46,869 shs
Average Volume: 111,876 shs
Market Capitalization: C$140.06 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Neovasc Stock (TSE:NVC)

Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.

November 9, 2023 | finance.yahoo.com

New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And Men

November 3, 2023 | markets.businessinsider.com

Centers for Medicare & Medicaid Services Establishes New Category I CPT® Add-On Code for Coronary IVL

December 6, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

October 26, 2023 | benzinga.com

Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2023 Results and Participation in Upcoming Investor Conference

October 10, 2023 | msn.com

Haemonetics Corp. Acquires Quebec’s OpSens Inc. in Major Medical Tech Deal

September 12, 2023 | finanznachrichten.de

Shockwave Medical, Inc.: Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024

September 11, 2023 | finance.yahoo.com

Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024

August 19, 2023 | forbes.com

Convert NovaCoin To Canadian Dollar

December 6, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

July 3, 2023 | benzinga.com

Heart Valve Devices Market to Cross USD 8.7 billion in 2031, expanding at a CAGR of 11.9%: TMR Report

June 14, 2023 | forbes.com

Convert NovaCoin To United States Dollar

June 14, 2023 | forbes.com

Convert NovaCoin To Sri Lankan Rupee

June 10, 2023 | forbes.com

Convert NovaCoin To Mexican Peso

June 10, 2023 | forbes.com

Convert NovaCoin To Chinese Yuan (Offshore)

May 23, 2023 | forbes.com

Convert NovaCoin To Bitcoin

May 21, 2023 | forbes.com

Convert NovaCoin To Ethereum

May 20, 2023 | forbes.com

Convert NovaCoin To Euro

May 18, 2023 | forbes.com

Convert NovaCoin To Ukrainian Hryvnia

May 17, 2023 | forbes.com

Convert NovaCoin To Georgian Lari

May 17, 2023 | forbes.com

Convert NovaCoin To Iraqi Dinar

September 15, 2022 | investing.com

NVC Lighting Holding Ltd (2222)

October 18, 2021 | stockhouse.com

Therma Bright Inc V.THRM

August 30, 2021 | finance.yahoo.com

Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference

August 19, 2021 | finanznachrichten.de

Neovasc Inc.: Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA

August 17, 2021 | finance.yahoo.com

Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA

August 10, 2021 | finanznachrichten.de

Neovasc Inc.: Neovasc Announces Second Quarter 2021 Financial Results

August 1, 2021 | markets.businessinsider.com

Sheng Siong to buy New World Centre strata unit from TA Corp for S$17.25 million

See More Headlines

Receive NVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: N/A
Sub-Industry: N/A
Sector: N/A
Current Symbol: TSE:NVC
CUSIP: N/A
CIK: N/A
Web: www.neovasc.com
Phone: +1-604-2704344
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 78,683,000
Free Float: N/A
Market Cap: C$140.06 million
Optionable: Not Optionable
Beta: N/A

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Paul L. Geyer
Independent Chairman of the Board
Fred Colen
President, Chief Executive Officer
Christopher Clark
Chief Financial Officer, Corporate Secretary
Brian McPherson
Chief Operating Officer
Vicki Lee Bebeau
Vice President - Clinical Affairs
Randy Lane
Vice President - Research & Development
Alexei J. Marko
Director
Jane H. Hsiao Ph.D. (Age 69)
Independent Director
Douglas Glen Janzen
Independent Director
William O'Neill (Age 61)
Independent Director

NVC Stock Analysis - Frequently Asked Questions

Should I buy or sell Neovasc stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NVC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVC, but not buy additional shares or sell existing shares.
View NVC analyst ratings or view top-rated stocks.
What other stocks do shareholders of Neovasc own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Neovasc (NVCN), PPL (PPL), Ballard Power Systems (BLDP), (CPXX) (CPXX), 155675 (BLD.TO) (BLD), Dundee Precious Metals (DPM), Fc Global Realty (FCRE), Top Ships (TOPS) and Birchcliff Energy (BIR).
How do I buy shares of Neovasc?: Shares of NVC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:NVC) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Neovasc Stock Price, News & Analysis (TSE:NVC)

About Neovasc Stock (TSE:NVC)

NVC Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

NVC Stock Analysis - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info